424 related articles for article (PubMed ID: 22010356)
21. Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment.
Zhu MT; Feng WY; Wang Y; Wang B; Wang M; Ouyang H; Zhao YL; Chai ZF
Toxicol Sci; 2009 Feb; 107(2):342-51. PubMed ID: 19023088
[TBL] [Abstract][Full Text] [Related]
22. Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver--magnetic nanoparticles in cancer treatment.
Krukemeyer MG; Krenn V; Jakobs M; Wagner W
J Surg Res; 2012 Jun; 175(1):35-43. PubMed ID: 21470623
[TBL] [Abstract][Full Text] [Related]
23. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization.
Ohno K; Mori C; Akashi T; Yoshida S; Tago Y; Tsujii Y; Tabata Y
Biomacromolecules; 2013 Oct; 14(10):3453-62. PubMed ID: 23957585
[TBL] [Abstract][Full Text] [Related]
24. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
25. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers.
Landmark KJ; Dimaggio S; Ward J; Kelly C; Vogt S; Hong S; Kotlyar A; Myc A; Thomas TP; Penner-Hahn JE; Baker JR; Holl MM; Orr BG
ACS Nano; 2008 Apr; 2(4):773-83. PubMed ID: 19206610
[TBL] [Abstract][Full Text] [Related]
27. [Study on chitosan-modified tripterygium glycoside nanoparticles and its renal targeting property].
Chen XK; Wei YH; Yao JN; Zhao YM; Shang XG; Li FZ
Zhongguo Zhong Yao Za Zhi; 2013 Feb; 38(4):548-52. PubMed ID: 23713281
[TBL] [Abstract][Full Text] [Related]
28. An insight into the metabolic responses of ultra-small superparamagnetic particles of iron oxide using metabonomic analysis of biofluids.
Feng J; Liu H; Zhang L; Bhakoo K; Lu L
Nanotechnology; 2010 Oct; 21(39):395101. PubMed ID: 20820093
[TBL] [Abstract][Full Text] [Related]
29. The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent.
Masoudi A; Madaah Hosseini HR; Shokrgozar MA; Ahmadi R; Oghabian MA
Int J Pharm; 2012 Aug; 433(1-2):129-41. PubMed ID: 22579990
[TBL] [Abstract][Full Text] [Related]
30. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
[TBL] [Abstract][Full Text] [Related]
31. Early-stage investigations of ultrasmall superparamagnetic iron oxide-induced signal change after permanent middle cerebral artery occlusion in mice.
Desestret V; Brisset JC; Moucharrafie S; Devillard E; Nataf S; Honnorat J; Nighoghossian N; Berthezène Y; Wiart M
Stroke; 2009 May; 40(5):1834-41. PubMed ID: 19286601
[TBL] [Abstract][Full Text] [Related]
32. The behavior after intravenous injection in mice of multiwalled carbon nanotube / Fe3O4 hybrid MRI contrast agents.
Wu H; Liu G; Zhuang Y; Wu D; Zhang H; Yang H; Hu H; Yang S
Biomaterials; 2011 Jul; 32(21):4867-76. PubMed ID: 21459436
[TBL] [Abstract][Full Text] [Related]
33. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors.
Weissleder R; Reimer P; Lee AS; Wittenberg J; Brady TJ
AJR Am J Roentgenol; 1990 Dec; 155(6):1161-7. PubMed ID: 2122660
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of MR relaxation effects of iron oxide particles in liver and spleen.
Majumdar S; Zoghbi S; Pope CF; Gore JC
Radiology; 1988 Dec; 169(3):653-8. PubMed ID: 3186986
[TBL] [Abstract][Full Text] [Related]
35. Ultrasmall cationic superparamagnetic iron oxide nanoparticles as nontoxic and efficient MRI contrast agent and magnetic-targeting tool.
Uchiyama MK; Toma SH; Rodrigues SF; Shimada AL; Loiola RA; Cervantes Rodríguez HJ; Oliveira PV; Luz MS; Rabbani SR; Toma HE; Poliselli Farsky SH; Araki K
Int J Nanomedicine; 2015; 10():4731-46. PubMed ID: 26251595
[TBL] [Abstract][Full Text] [Related]
36. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
37. Nanomagnetism reveals the intracellular clustering of iron oxide nanoparticles in the organism.
Levy M; Wilhelm C; Luciani N; Deveaux V; Gendron F; Luciani A; Devaud M; Gazeau F
Nanoscale; 2011 Oct; 3(10):4402-10. PubMed ID: 21931920
[TBL] [Abstract][Full Text] [Related]
38. A novel micelle-forming material used for preparing a theranostic vehicle exhibiting enhanced in vivo therapeutic efficacy.
Chen HP; Chen MH; Tung FI; Liu TY
J Med Chem; 2015 May; 58(9):3704-19. PubMed ID: 25933159
[TBL] [Abstract][Full Text] [Related]
39. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
Sahu SK; Maiti S; Maiti TK; Ghosh SK; Pramanik P
J Drug Target; 2011 Feb; 19(2):104-13. PubMed ID: 20367067
[TBL] [Abstract][Full Text] [Related]
40. Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
Prashant C; Dipak M; Yang CT; Chuang KH; Jun D; Feng SS
Biomaterials; 2010 Jul; 31(21):5588-97. PubMed ID: 20434210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
